Swastika Ganguly

Title: Swastika Ganguly: Innovator in Anti-Inflammatory Research

Introduction

Swastika Ganguly is a notable inventor based in Ranchi, India. She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory agents. With a total of two patents to her name, her work focuses on innovative compounds that target specific biological pathways.

Latest Patents

Ganguly's latest patents include the selective COX-2 inhibition of 2-(substituted benzyl)-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-ones and 4-fluoro-N-(4-oxo-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl)benzamide. These compounds are identified as COX-2 inhibitors and are useful as anti-inflammatory and pain agents. The patents also describe methods of synthesizing these compounds, pharmaceutical compositions comprising them, and methods of using the compounds for treating inflammation, pain, or any other COX-2 mediated disorder.

Career Highlights

Ganguly is currently associated with King Fahd University of Petroleum and Minerals, where she continues her research in the field of pharmaceuticals. Her work has garnered attention for its potential applications in treating various inflammatory conditions.

Collaborations

Some of her notable coworkers include Katharigatta N Venugopala and Pran Kishore Deb, who have collaborated with her on various research projects.

Conclusion

Swastika Ganguly's innovative research in anti-inflammatory agents highlights her contributions to the pharmaceutical industry. Her patents reflect a commitment to advancing medical science and improving treatment options for patients.